α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines-Reference-Cited by-全球学者库

α1-Blockers and 5α-Reductase Inhibitors Are the Most Recommended Drugs in Treating Benign Prostatic Hyperplasia: An Evidence-Based Evaluation of Clinical Practice Guidelines

Published:2020-03-25 Issue: Volume:11 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Xu Xiao-Feng,Liu Guo-Xiong,Zhu Cong,Qiao Xi-Min,Yu Shao-Fu,Deng Tong,Jin Ying-Hui

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference29 articles.

1. Management of benign prostatic hyperplasia - South African Urological Association guideline;Bereczky;Samj South Afr. Med. J.,2006

2. Hiperplasia prostática benigna;Cavalcanti,2006

3. Consensus on Management of Benign Prostatic Hyperplasia;Chang,1998

4. Lower urinary tract symptoms in men: management;Chapple,2015

5. World Health Organization Consensus Committee recommendations concerning the diagnosis of BPH;Cockett;Prog. Urol.,1991

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diacerein provokes apoptosis, improves redox balance, and downregulates PCNA and TNF-α in a rat model of testosterone-induced benign prostatic hyperplasia: A new non-invasive approach;PLOS ONE;2023-11-09

2. Two-year Outcomes after Transurethral Prostate Resection Post-prostatic Artery Embolization Versus Transurethral Prostate Resection Alone For Giant Benign Prostatic Hyperplasia;UROL J;2023

3. Comparative Efficacy of Different Drugs for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Bayesian Network Meta-Analysis;Frontiers in Pharmacology;2022-03-07

4. An Updated Meta-Analysis of the Efficacy and Safety of Prostatic Artery Embolization vs. Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia;Frontiers in Surgery;2021-12-15

5. Yohimbine hydrochloride inhibits benign prostatic hyperplasia by downregulating steroid 5α-reductase type 2;European Journal of Pharmacology;2021-10